SAPIENT CAPITAL LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1998653 INDIANAPOLIS, IN

Position in VRTX

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$8,946,604

+$465,917 QoQ

Shares Held

18,011

-5.2% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#13

of 146 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

SAPIENT CAPITAL LLC holds $34,121,163 across 5 Biotechnology names. VRTX ranks #2 (26.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	92,162	$24,581,448
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	18,011	$8,946,604
3	EXEL	Exelixis, Inc.	5,658	$307,851
4	NUVB	Nuvation Bio Inc.	31,450	$178,636
5	INTS	Intensity Therapeutics, Inc.	26,006	$106,624

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,946,604	18,011	-5.2%	Shares	Sole	2026-07-09
2026-03-31	$8,480,687	18,992	-44.7%	Shares	Sole	2026-04-08
2025-12-31	$15,561,128	34,324	+0.0%	Shares	Sole	2026-02-05
2025-09-30	$13,437,560	34,311	-5.5%	Shares	Sole	2025-10-17
2025-06-30	$16,165,212	36,310	+0.9%	Shares	Sole	2025-07-09
2025-03-31	$17,451,580	35,996	+0.6%	Shares	Sole	2025-04-15
2024-12-31	$14,415,049	35,796	+1.4%	Shares	Sole	2025-01-29
2024-09-30	$16,416,393	35,298	+0.1%	Shares	Sole	2024-10-11
2024-06-30	$16,524,723	35,255	-0.1%	Shares	Sole	2024-07-15
2024-03-31	$14,745,302	35,275	+2.3%	Shares	Sole	2024-04-22
2023-12-31	$14,032,008	34,486	—	Shares	Sole	2024-02-06
No filing history on record for this holder in this stock.